Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2013
10/30/2013CN102106919B Method for controlling quality in extraction process of traditional Chinese medicine chuanhong blood circulation-activating capsules
10/30/2013CN102036667B Compositions comprising quinazoline derivatives, preparation methods and uses thereof
10/30/2013CN101885684B Aromatic acid pro-drug with nitrogen monoxide donor, and preparation method and application thereof
10/30/2013CN101835770B Condensed compounds with activity at estrogen receptors
10/30/2013CN101810638B Preparation method of endogenous interferon inducer injection and nanometer microencapsulation solution
10/30/2013CN101768202B Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof
10/30/2013CN101768149B Beta- aminoketone (alkamine) derivatives and use thereof
10/30/2013CN101676286B Azaindoles useful as inhibitors of JAK and other protein kinases
10/30/2013CN101578266B Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
10/30/2013CN101426783B Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
10/30/2013CN101257946B Pharmaceutical dosage form containing active principle combination of nifedipine and/or nisoldipine and of angiotensin II antagonist
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569446 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/29/2013US8569339 Soluble guanylate cyclase activators
10/29/2013US8569288 Thienotriazolodiazepine derivatives active on apo A
10/29/2013US8569283 Compounds and compositions as c-Kit kinase inhibitors
10/29/2013US8569260 N-pyrazole A2A receptor agonists
10/29/2013US8569248 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
10/29/2013US8569058 Nerve regeneration promoters
10/29/2013US8568805 Cognitive function
10/29/2013US8568793 Sodium nitrite-containing pharmaceutical compositions
10/29/2013US8568731 Staphylococcus aureus antigenic polypeptides and compositions
10/29/2013CA2603254C New bicyclic angiotensin ii agonists
10/29/2013CA2458001C Regulation of immune responses by manipulation of intermediary metabolite levels
10/29/2013CA2434643C Peptides for activation and inhibition of.delta.pkc
10/24/2013WO2013158871A1 Use of erythropoietin and derivatives for treating hypertension
10/24/2013WO2013158841A1 Peptide mimotopes to oxidation specific epitopes
10/24/2013WO2013158782A2 Methods and compositions for treating cardiac arrhythmias
10/24/2013WO2013158251A1 Fluorinated benzofuran derivatives
10/24/2013WO2013157840A1 Composite composition having improved stability and containing amlodipine and rozaltan
10/24/2013WO2013157792A1 Bicyclic heteroaryl derivative and pharmaceutical composition comprising same
10/24/2013WO2013157528A1 Bicyclic compound
10/24/2013WO2013157511A1 Arylaminopyrazole derivative
10/24/2013WO2013156505A1 Agents for treating disorders involving modulation of ryanodine receptors
10/24/2013WO2013156423A1 New phenyl-tetrahydroisoquinoline derivatives
10/24/2013WO2013155742A1 Use of liuweidihuang preparation in preparing drugs for post-operative treatment of cardiac stenting
10/24/2013WO2013155586A1 Process for preparing inclusion compounds enclosing cyclodextrins and drugs, using a continuous-flow system
10/24/2013WO2013155585A1 Sustained release device for thalidomide and use in eye diseases causing neovascularisation
10/24/2013WO2013022846A3 Flavonoid compounds
10/24/2013US20130281705 Compounds for the treatment of metabolic disorders
10/24/2013US20130281508 MicroRNA target site for cell- or tissue-specific inhibition of expression of a transgene
10/24/2013US20130281419 Therapeutic Uses for an Aminosterol Compound
10/24/2013US20130281415 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
10/24/2013US20130281406 Thiazole derivatives and their use as p2y12 receptor antagonists
10/24/2013US20130280330 Microsphere drug carrier, preparation method, composition and use thereof
10/24/2013US20130280234 Treatment and Composition for Wound Healing
10/24/2013CA2861060A1 New phenyl-tetrahydroisoquinoline derivatives
10/23/2013EP2653469A1 Pyrazole derivative
10/23/2013EP2653466A1 Agents for treating disorders involving modulation of ryanodine receptors
10/23/2013EP2653167A1 Cell migration modulator
10/23/2013EP2653158A1 Therapeutic agent for blood-brain barrier disruption syndrome
10/23/2013EP2653157A1 Astaxanthin for improving muscle atrophy
10/23/2013EP2652137A1 Lar protein-specific ligand
10/23/2013EP2651915A1 Continuous arycyclic compound
10/23/2013EP2651895A1 Oxime compounds as hdl-cholesterol raising agents
10/23/2013EP2651430A1 Biological activity of placental protein 13
10/23/2013EP2651422A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
10/23/2013EP2651413A1 Novel inhibitors of matrix metalloproteinases
10/23/2013EP2651401A2 Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin
10/23/2013EP2651389A1 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
10/23/2013EP2651251A1 Composition for the treatment of metabolic disorders
10/23/2013EP2651248A2 Functional food preparation and use thereof
10/23/2013CN103370309A Substituted N-phenethyltriazoloneacetamides and use thereof
10/23/2013CN103370102A Novel oxime derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10/23/2013CN103370067A Novel oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10/23/2013CN103370065A Novel benzyl azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10/23/2013CN103361347A Micro RNA (Ribonucleic Acid) aiming at angiogenin 2
10/23/2013CN103360457A Androstanedione derivative crystal form and preparation method therefor
10/23/2013CN103360390A Pyrrocoline formylmethyl p-methane sulfonamide phenylethylamine derivative and its medical application
10/23/2013CN103360388A 5-Amino-1,4-dihydro-1,8-naphthyridine derivatives and pharmaceutical compositions as well as uses thereof
10/23/2013CN103360381A New crystal form of Azilsartan, and preparation method and application thereof
10/23/2013CN103360276A Crystal form, preparation method and application of agomelatine, as well as medicine composition
10/23/2013CN103357000A Progressive stroke retardant
10/23/2013CN103356996A Treatment of acute coronary syndrome with GLP-1
10/23/2013CN103356991A Application of pain-relieving and illness-eliminating granule in preparing drugs for curing cerebral thrombosis
10/23/2013CN103356952A Chinese medicine composition for treating arrhythmia
10/23/2013CN103356951A Traditional Chinese medicine composition for treating cardiac insufficiency
10/23/2013CN103356941A Health-care medicinal liquor having a plurality of functions
10/23/2013CN103356912A Medicine for treating tachycardia and preparation method thereof
10/23/2013CN103356909A Notopterygium root containing medicine composition for treating stroke and preparation thereof
10/23/2013CN103356908A Radix achyranthis bidentatae containing medicine composition for treating stroke and preparation thereof
10/23/2013CN103356906A Traditional Chinese medicine preparation for caring insomniac and preparation method
10/23/2013CN103356902A Gastrodia elata containing medicine composition for treating stroke and preparation thereof
10/23/2013CN103356898A Capsule for treating diabetic retinopathy syndrome
10/23/2013CN103356861A Traditional Chinese medicine extract for treating ischemic cerebrovascular disease and preparation method thereof
10/23/2013CN103356856A Health care blood pressure reducing tea
10/23/2013CN103356844A Chitosan oligosaccharide compound preparation and application thereof to preparation of drugs for treating skin diseases
10/23/2013CN103356822A Preparation for treating coronary disease and preparation method thereof
10/23/2013CN103356817A Formula for treating acute thrombophlebitis
10/23/2013CN103356809A Traditional Chinese medicine for treating cerebral infarction
10/23/2013CN103356804A Traditional Chinese medicine for treating haemorrhoids, and preparation method thereof
10/23/2013CN103356796A Blood stasis removing particles and preparation method thereof
10/23/2013CN103356760A Vasculitis treatment medicine
10/23/2013CN103356752A Corydalisdecumbens(Thunb.)Pers. injection and preparation method thereof
10/23/2013CN103356731A Xuesaitong tablet containing eucommia extract and panax notoginseng saponins and application thereof
10/23/2013CN103356718A Slowly-released permeating cardiac paste
10/23/2013CN103356712A Changbai mountain oviductus ranae pure powder particles and preparation method thereof
10/23/2013CN103356710A Treatment of diseases and disorders using placental stem cells
10/23/2013CN103356687A Use of ivermectin and its derivative
10/23/2013CN103356686A Application of Houttuynoid B in preparation of medicine for treating or preventing chronic heart failure
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 1595